Inactive Ingredient Search for Approved Drug Products

• Share
• Tweet
• Linkedin
• Pin it
• More sharing options
  • Linkedin
  • Pin it
• Email
• Print

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with X

	Quarter	Inactive Ingredient	Route of Administration	Dosage Form	Maximum Potency per unit dose	Maximum Daily Exposure	Status
9357	Q3 2021	XANTHAN GUM	ORAL	GRANULE, FOR SUSPENSION	259.40 mg		MDE Replacement
9357	Q4 2021	XANTHAN GUM	ORAL	GRANULE, FOR SUSPENSION		450 mg	MDE Replacement
9369	Q3 2021	XANTHAN GUM	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE	4.00 mg		MDE Replacement
9369	Q4 2021	XANTHAN GUM	ORAL	TABLET, CHEWABLE, EXTENDED RELEASE		6 mg	MDE Replacement
9379	Q3 2021	XANTHAN GUM	TOPICAL	CREAM	0.75 %w/w		MDE Replacement
9379	Q4 2021	XANTHAN GUM	TOPICAL	CREAM		45.6 mg	MDE Replacement
9383	Q3 2021	XYLITOL	BUCCAL	GUM, CHEWING	506.13 mg		MDE Replacement
9383	Q4 2021	XYLITOL	BUCCAL	GUM, CHEWING		9542.6 mg	MDE Replacement
9394	Q3 2021	XYLITOL	SUBLINGUAL	SPRAY	2.70 mg/ 1.00 ml		MDE Replacement
9394	Q4 2021	XYLITOL	SUBLINGUAL	SPRAY		21.6 mg	MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021